BioCorRx (BICX) Other financing activities (2018 - 2024)

BioCorRx (BICX) posted Other financing activities of $2584.0 for Q1 2024, down 99.63% sequentially from $703114.0 in Q2 2019.

BioCorRx (BICX) Other financing activities (2018 - 2024) Analysis & Trends

BioCorRx has reported Other financing activities for 3 years, with the latest figure at $2584.0 in Q1 2024.

Quarterly Other financing activities changed N/A year-over-year to $2584.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $2584.0 (down 99.77% YoY) and the FY2024 annual result came in at $2584.0, changed N/A from the prior year.
Other financing activities eased to $2584.0 in Q1 2024 per BICX's latest filing, from $703114.0 in the prior quarter.
Over five years, Other financing activities peaked at $2584.0 in Q1 2024 and troughed at $2584.0 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn
10	BioCorRx	1.49 Mn	1.47 Mn	-

Download Data